Entering text into the input field will update the search result below

Hologic: Post-Covid World Proving To Be A Nuisance On Profitability (Rating Downgrade)

Sep. 13, 2023 8:00 AM ETHologic, Inc. (HOLX) Stock1 Comment
Zach Bristow profile picture
Zach Bristow


  • The latest investment findings suggest a revised rating of "hold" for Hologic, Inc.
  • HOLX needs catalysts such as sales growth, higher profits, or valuation factors to drive its stock price higher.
  • The company's COVID-era sales and profits are declining, and the rate of earnings produced on capital deployed has taken a hit.
  • Net-net, revise to hold.

Wall street sign in New York with New York Stock Exchange background

naphtalina/iStock via Getty Images

Investment briefing

In the last publication on Hologic, Inc. (NASDAQ:HOLX), it was noted: "If new data arrives, to suggest [the rating] needs revising, it will be done...". Based on the latest investment findings, it would appear the data has changed in

This article was written by

Zach Bristow profile picture
Strategist, global markets, at Bernard Holdings. Objective view on the directional bias of markets. Technical expertise bridges the complex relationships between value drivers, capital flows and price action. Clients are represented over the cross-section of financial markets, from speculators, hedgers, long-term traders and the public. Research covers investment securities and futures markets.Shoot me a message to talk trade ideas or portfolio construction. Disclaimer:All research is strictly for informational purposes only. Not to be considered investment advice. Please remember to conduct your own due diligence.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments (1)

This is a definite AI play in healthcare and diagnosis
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!

About HOLX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on HOLX

Related Stocks

SymbolLast Price% Chg
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.